Non-alcoholic fatty liver disease

Non-alcoholic fatty liver disease, or NAFLD – a disease associated with metabolic disorders without regard to alcohol.
Its development is influenced by a number of harmful factors, among which are the following: improper and / or malnutrition, overweight, hormonal disorders, low-active lifestyle, nervous stress, and much more.

It is important to know that liver obesity is most common in people with increased body mass. A combination of obesity and alcohol abuse increases the risk of fatty liver disease. According to statistics, women are more susceptible to fatty degeneration of the liver than men, and the most dangerous age for the development of the disease is 45-55 years.

When disorders of fat metabolism in the liver cells increases the content of lipids (fats), why the liver often increases in size and disrupts its work. The first stage of the disease is called steatosis. The danger of this disease is a long absence of symptoms, and gradual progression.

After some time, in the absence of measures to correct weight and lifestyle, inflammation forms in liver cells with excess fat. This condition is called steatohepatitis. Clinically, steatohepatitis may manifest with severity, dull pain, dyspeptic disorders. Subjectively, a person may experience increased fatigue, irritability, a decrease in concentration due to impaired detoxification of the liver. The doctor detects an increase in liver and pain on palpation, and in laboratory tests the level of ALT, AST, GGTP increases, which indicates the activity of the inflammatory process and the death of liver cells. However, sometimes steatohepatitis may be asymptomatic for a long time.

The next stage of the disease is fibrosis. In fibrosis, the liver cells are replaced by connective tissue, which negatively affects the functioning of the liver and the state of the body as a whole. Such important functions of the liver as detoxification (purification from toxins), protein synthesis, hormone vitamins, digestive function and much more are significantly impaired. At this stage, the symptoms listed above are aggravated, and one of the most prominent manifestations of the disease is marked asthenia (fatigue, weakness), poor mood, decreased concentration and attention, due to an increase in the body’s toxins.

The last and irreversible stage of NAFLD (non-alcoholic fatty liver disease) is cirrhosis (5-10% of cases during 10-20 years). At this stage, chronic liver failure is formed, and the symptoms of intoxication increase, the quality of life of a sick person and his relatives decreases significantly. Externally, symptoms appear ascites (accumulation of fluid in the abdominal cavity), tremor, yellowing of the sclera and skin, sleep disturbance, increased irritability, impaired cognitive (cognitive, mental) function. This stage is usually fatal.

Treatment of fatty liver disease

Treatment of fatty liver disease must begin at the earliest stages.
In case of fatty liver dystrophy, it is first of all necessary to create conditions conducive to reducing the toxic load on the liver and restoring its cells. For this you need: the elimination of alcohol, control taken drugs harmful to the liver, a diet low in fat, an active lifestyle.
An important therapeutic goal is a gradual weight loss of 500-1000 g per week (more dramatic weight loss only worsens the course of the disease). Moderate weight reduction leads to an improvement in the main clinical and laboratory parameters. Drug therapy using insulin sensitizers, hepatoprotectors and antioxidants can help in achieving the goals.

To reduce the toxic load on the body, as well as to normalize the work of the liver, the drug Hepa-Merz in granules can be recommended, which can have a complex effect of amino acids in the liver cells:
1. Clears toxins
2. Restores the energy of liver cells
3. Includes liver function.
4. Improves metabolism

An important advantage of Hepa-Merz is the onset of action within 15-25 minutes.